Patient info Search Menu

OLMETEC 40MG TABLETS – Summary of Product Characteristics (SmPC) for healthcare professionals

Status:
No longer supplied Key facts
Medicine strength:
40 mg
Still supplied:
The same active substance, strength and form in the NHS Dictionary of Medicines and Devices (dm+d). Ask your pharmacist or doctor before changing to another make.
Other strengths and forms:
Contains active substance:

Summary of Product Characteristics (SmPC) - OLMETEC 40MG TABLETS

1. NAME OF THE MEDICINAL PRODUCT

Not applicable

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Not applicable

3. PHARMACEUTICAL FORM

Not applicable

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

Not applicable

4.2. Posology and method of administration

Not applicable

4.3. Contraindications

Not applicable

4.4. Special warnings and precautions for use

Not applicable

4.5. Interactions with other medicinal products and other forms of interaction

Not applicable

4.6. Pregnancy and lactation

Not applicable

4.7. Effects on ability to drive and use machines

Not applicable

4.8. Undesirable effects

Not applicable

4.9. Overdose

5. PHARMACOLOGICAL PROPERTIES

5.1. Pharmacodynamic properties

Not applicable

5.2. Pharmacokinetic properties

Not applicable

5.3. Preclinical safety data

Not applicable

6. PHARMACEUTICAL PARTICULARS

6.1. List of excipients

Not applicable

6.2. Incompatibilities

Not applicable

6.3. Shelf life

Not applicable

6.4. Special precautions for storage

Not applicable

6.5. Nature and contents of container

Not applicable

6.6. Instruction for use and handling (, and disposal)

Not applicable

Administrative Data

7. MARKETING AUTHORISATION HOLDER

Not applicable

8. MARKETING AUTHORISATION NUMBER

Not applicable

9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

Not applicable

10. DATE OF REVISION OF THE TEXT

Not applicable

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 15184/0450

MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about OLMETEC 40MG TABLETS

What these facts mean

Active substance? Olmesartan
Strength? 40 mg
Pharmaceutical form? Oral tablet
How is it taken? Oral
Is it available?? No, all its packs are listed as discontinued (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)?
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09C Angiotensin II receptor blockers (ARBs), plain
        1. C09CA Angiotensin II receptor blockers (ARBs), plain
          1. C09CA08 olmesartan medoxomil
Marketing authorisation? PL 15184/0450
Codes? BNF 02050502

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 11.1.0 of 9 November 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.